New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. (Record no. 20198485)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01532 a2200397 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516003301.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201103s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1873-4995 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.jconrel.2010.09.004 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Tinkov, Steliyan |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20110325 |
| 245 00 - TITLE STATEMENT | |
| Title | New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Journal of controlled release : official journal of the Controlled Release Society |
| Date of publication, distribution, etc. | Dec 2010 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 368-72 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibiotics, Antineoplastic |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Contrast Media |
| General subdivision | chemistry |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Doxorubicin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Delivery Systems |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Microbubbles |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pancreatic Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rats |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rats, Inbred Lew |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ultrasonics |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Coester, Conrad |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Serba, Susanne |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Geis, Nicolas A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Katus, Hugo A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Winter, Gerhard |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bekeredjian, Raffi |
| 773 0# - HOST ITEM ENTRY | |
| Title | Journal of controlled release : official journal of the Controlled Release Society |
| Related parts | vol. 148 |
| -- | no. 3 |
| -- | p. 368-72 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.jconrel.2010.09.004">https://doi.org/10.1016/j.jconrel.2010.09.004</a> |
| Public note | Available from publisher's website |
No items available.